OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Organ Transplantation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Survival in adult lung transplantation: where are we in 2020?	137
Uterus transplantation worldwide: clinical activities and outcomes	46
Artificial intelligence and organ transplantation: challenges and expectations	28
Nonmedical barriers to early steps in kidney transplantation among underrepresented groups in the United States	25
Current status of porcine islet xenotransplantation	24
The artificial pancreas	22
Gender and racial disparities in the transplant surgery workforce	21
Ethical considerations in xenotransplantation: a review	17
Update on islet cell transplantation	15
Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis	15
Elucidating measures of systemic racism to mitigate racial disparities in kidney transplantation	15
Update on immunosuppressive strategies in intestinal transplantation	14
Machine-learning algorithms for predicting results in liver transplantation: the problem of donor–recipient matching	14
Mitochondria and ischemia reperfusion injury	14
Update on Nocardia infections in solid-organ transplantation	14
Viability testing during liver preservation	14
The time is now: antimicrobial stewardship in solid organ transplantation	14
The current status and outlook of trachea transplantation	13
Normothermic machine perfusion of donor-lungs ex-vivo: promoting clinical adoption	13
Biomarkers of rejection in liver transplantation	13
Antibody-mediated rejection: prevention, monitoring and treatment dilemmas	13
Gender disparities in transplantation	12
New insights into the indications for intestinal transplantation	12
Artificial intelligence in transplantation (machine-learning classifiers and transplant oncology)	12
Donor-specific antibodies in lung transplantation	11

Current status of pediatric mechanical circulatory support	11
New concepts in chronic antibody-mediated kidney allograft rejection: prevention and treatment	11
Long-term outcomes of intestinal transplantation	11
Role of the purinergic signaling network in lung ischemia-reperfusion injury	11
The evolving role of ECMO in liver transplantation	11
Pancreas preservation: clinical practice and future developments	10
Cell-free DNA in lung transplantation: research tool or clinical workhorse?	10
Grant monitoring after intestinal transplantation	10
Cardiac evaluation of the kidney or liver transplant candidate	10
Current status of normothermic ex-vivo perfusion of cardiac allografts	10
Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing	10
The past the present and the future of face transplantation	10
An update on frailty in lung transplantation	10
Geographic disparities in transplantation	10
Disparities in heart and lung transplantation	10
Current status of adult liver transplantation: utilization of living donor versus deceased donor graft	9
Immune benefit of combined heart and liver transplantation	9
Comparing bowel lengthening procedures: which, when, and why?	9
Novel approaches in uterus transplantation	9
Alloimmunity in pancreas transplantation	9
Ethics of allocation of donor organs	9
Donor-specific antibody and sensitized patients in intestinal transplantation	9
MicroRNAs: small molecules, big effects	8
Cardiac donation after circulatory death	8
Pediatric kidney transplantation in the United States	8
Intestinal transplantation	8
Liver perfusion strategies: what is best and do ischemia times still matter?	8
The role of non-HLA antibodies in solid organ transplantation: a complex deliberation	8
Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process	8
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation	8
The emerging psychosocial profile of the adult congenital heart disease patient	8
The use of organs from hepatitis C virus-viremic donors into uninfected recipients	8
Developments in immunosuppression	8
Access to liver transplantation for minority populations in the United States	8
Current status of left lobe adult to adult living donor liver transplantation	7
Redefining marginality: donor lung criteria	7
Lung transplant programs in developing countries: challenges, solutions, and outcomes	7
Recent advances in precision medicine for individualized immunosuppression	7
Quality of life after intestinal transplantation	7
Total artificial heart as a bridge to transplantation	7
Machine learning methods in organ transplantation	7
Psychosocial considerations in the combined bariatric surgery and organ transplantation population: a review of the overlapping pathologies and outcomes	7
Normothermic regional perfusion for donation after circulatory death donors	7
Expedited placement to maximize utilization of marginal organs	6
Heart transplantation candidacy	6
Expanding access to pancreas transplantation for type 2 diabetes mellitus	6
Mycobacterium tuberculosis in solid organ transplant donors and recipients	6
Considerations and experience driving expansion of combined heart–liver transplantation	6
Procedural mechanical support for lung transplantation	6
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	6

Antibody-medicated rejection after heart transplantation: diagnosis and clinical implications	6
Technical advancements in epigenomics and applications in transplantation	6
Obesity and kidney transplantation	6
Delayed graft function: current status and future directions	6
The current state of artificial intelligence in cardiac transplantation	6
The impact of the gut microbiome on liver transplantation	6
Skin xenotransplantation: technological advances and future directions	6
Marginal parental donors for pediatric living donor liver transplantation	6
New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients	6
Precision transplant pathology	6
Cardiomyopathies in children: classification, diagnosis and treatment	5
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	5
Uterus transplantation – donor and recipient work-up	5
Recurrent glomerulonephritis after kidney transplantation: a practical approach	5
Ethical and societal challenges in penis transplantation	5
Organ allocation in the age of the algorithm: avoiding futile transplantation – utility in allocation	5
Current status: meeting the regulatory goals of your liver transplant program	5
Age disparities in transplantation	5
Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics	5
Disparities in living donation	5
Intestinal transplantation: an overview of the recent experimental studies	5
The solid organ transplant recipient with SARS-CoV-2 infection	5
Normothermic machine perfusion of kidneys: current strategies and future perspectives	5
Pancreas transplantation	5
Kidney and pancreas transplant candidacy	5
New insights into the microbiome in kidney transplantation	5
Uterus transplantation: ethical considerations	5